Inventor
Walter Boudewijn Leopold Wouters
Inventor
Kapellen, BE
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes26%
Y02ATechnologies for adaptation to climate change6%
C07HSugars3%
C12NMicroorganisms or enzymes3%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms3%
C04BLime, magnesia1%
PatentTitleYear
10,150,757Quinazolinone derivatives as PARP inhibitors20189,522,905'Quinazolinone derivatives as PARP inhibitors'20169,255,080'Quinazolinedione derivatives as PARP inhibitors'20169,115,084'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20158,946,221'Phthalazine derivatives as PARP inhibitors'20158,623,884'Quinazolinedione derivatives as PARP inhibitors'20148,623,872'Quinazolinone derivatives as PARP inhibitors'20148,524,714'7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20138,450,486'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20138,188,103'Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors'20128,080,557'Quinazolinedione derivatives as PARP inhibitors'20118,071,612'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20117,928,104'7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20117,879,857'6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors'20117,855,207'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors'20107,803,795'Phthalazine derivatives as parp inhibitors'20107,803,600'Micromonospora species that produces a bafilomycin-like metabolite'20107,652,014'Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20107,214,705'Bafilomycin-like metabolite from a novel micromonospora species'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2018Patents assigned to JANSSEN PHARMACEUTICA NV (18)· patent assignee history
2007–2018Based in Kapellen, BE· patent location history
2011–2014Patents assigned to SOMERS MARIA VICTORINA FRANCISCA (8)· patent assignee history
2011–2014Patents assigned to WOUTERS WALTER BOUDEWIJN LEOPOLD (8)· patent assignee history
2011–2014Patents assigned to VAN DUN JACOBUS ALPHONSUS JOSEPHUS (7)· patent assignee history
2011–2014Patents assigned to GUILLEMONT JEROME EMILE GEORGES (5)· patent assignee history
2015Based in Beerse, BE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 18 | 2007–2018 |
| SOMERS MARIA VICTORINA FRANCISCA | 8 | 2011–2014 |
| WOUTERS WALTER BOUDEWIJN LEOPOLDself | 8 | 2011–2014 |
| VAN DUN JACOBUS ALPHONSUS JOSEPHUS | 7 | 2011–2014 |
| GUILLEMONT JEROME EMILE GEORGES | 5 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kapellen, BE | 18 | 2007–2018 |
| Beerse, BE | 1 | 2015 |